DÄ internationalArchiveReferences
References

Review article

The Uses and Limitations of Whole-Body Magnetic Resonance Imaging

Dtsch Arztebl Int 2010; 107(22): 383-9. DOI: 10.3238/arztebl.2010.0383

Schmidt, G; Dinter, D; Reiser, M F; Schoenberg, S O

1.Schmidt GP, Wintersperger B, Graser A, Baur-Melnyk A, Reiser MF, Schoenberg SO: High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study. Invest Radiol 2007; 449–59. MEDLINE
2. Kruger DG, Riederer SJ, Grimm RC, Rossman PJ: Continuously moving table data acquisition method for long FOV contrast-enhanced MRA and whole-body MRI. Magn Reson Med 2002; 47: 224–31. MEDLINE
3. Goehde SC, Hunold P, Vogt FM, et al.: Full-body cardiovascular and tumor MRI for early detection of disease: feasibility and initial experience in 298 subjects. AJR 2005; 184: 598–611. MEDLINE
4. Kramer H, Michaely K, Nikolaou K, Reiser MF, Schoenberg SO: State of the art cardiovascular imaging with parallel imaging techniques on a whole body MR scanner: experience in more than 200 individuals. Eur Radiol 2006; 16 (S): 232.
5. Baumgart D, Egelhof T: Präventives Ganzkörperscreening unter Einbeziehung moderner Bildgebung mit Hilfe der Magnetresonanztomographie. Herz 2007; 32: 387–94. MEDLINE
6. American Joint Committee on Cancer: AJCC Cancer Staging Manual (6th edition). 2002; New York: Springer.
7. Plathow C, Walz M, Lichy MP, et al.: Kostenüberlegungen zur Ganzkörper-MRT und PET-CT im Rahmen des onkologischen Stagings. Radiologe 2008; 48: 384–96. MEDLINE
8. Goyen M, Schlemmer HP: Ganzkörper-MRT – diagnostische Strategie der Zukunft? Radiologe 2004; 47: 904–14.
9. Schmidt GP, Baur-Melnyk A, Herzog P, et al.: High-resolution whole-body MRI tumor staging with the use of parallel imaging versus dual modality PET-CT: experience on a 32-channel system. Invest Radiol 2005; 40: 743–53. MEDLINE
10. Takahara T, Imay Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M: Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004: 22: 275–82. MEDLINE
11. Rao SX, Zeng MS, Chen CZ, et al.: The value of diffusion-weighted imaging in combination with T2-weighted imaging for rectal cancer detection. Eur J Radiol 2008; 65: 299–303. MEDLINE
12. Steinborn M, Tiling R, Heuck A, Brügel M, Stäbler A, Reiser M: Diagnostik der Metastasierung im Knochenmark mittels MRT. Der Radiologe 2000; 40: 826–34. MEDLINE
13. Semelka RC, Worawattanakul S, Kelekis NL, et al.: Liver lesion detection, characterization, and effect on patient managment: comparison of single-phase spiral CT and current MR techniques. J Magn Reson Imaging 1997; 7: 1040–7. MEDLINE
14. Antoch G, Vogt FM, Freudenberg LS, et al.: Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 2003; 290: 3199–206. MEDLINE
15. Schmidt GP, Baur-Melnyk A, Haug A, et al.: Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. Eur Radiol 2009; 19: 1366–78. MEDLINE
16. Schmidt GP, Baur-Melnyk A, Haug A, et al.: Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT. Eur J Radiol 2008; 65: 47–58. MEDLINE
17. Schlemmer HP, Schäfer J, Pfannenberg C, Radny P, Korchidi S, Müller-Horvat C: Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system: initial experiences. Invest Radiol 2005; 40: 64–71. MEDLINE
18. Ghanem N, Lohrmann C, Engelhardt M, et al.: Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey. Eur Radiol 2006; 16: 1005–14. MEDLINE
19. Baur-Melnyk A, Buhmann S, Becker C, et al.: Whole-body MRI versus whole-body MDCT for staging of multiple myeloma. Am J Roentgenol 2008; 190: 1097–104. MEDLINE
20. Baur A, Stäbler A, Nagel D, et al.: Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon? Cancer 2002; 95: 1334–45. MEDLINE
21. Dinter DJ, Neff WK, Klaus J: Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy. Ann Hematol 2009; 88: 457–64. MEDLINE
22. Weckbach S, Michaely HJ, Friedrich D, Schewe S, Reiser MF, Glaser C: Whole body MR Imaging in psoriatic arthritis: development of an imaging protocol and evaluation in 25 patients. Eur Radiol 2007; (Suppl.1) 17: 139.
23. Weckbach S, Findeisen HM, Schoenberg SO, et al.: Systemic cardiovascular complications in patients with long-standing diabetes mellitus: comprehensive assessment with whole-body magnetic resonance imaging/magnetic resonance angiography. Invest Radiol 2009; 44: 242–50. MEDLINE